Administrative Core supports a center advancing outpatient antiviral drugs for coronaviruses
Official title: Administrative Core
Funded at Stanford University · NIH-11587808 · Data updated 2026-11-12
A Stanford-led center is coordinating and guiding multiple projects to develop outpatient antiviral drugs for coronaviruses and other RNA viruses with pandemic potential.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | May 16, 2022 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $240,434 |
| NIH project number | 4U19AI171421-02 |
| Project ID | NIH-11587808 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with coronavirus infections or at-risk populations could benefit from future antiviral treatments developed through this center.
✕Less likely to help
This core does not directly test a treatment in patients; it funds and coordinates research activities.
What this research studies
This grant funds the Administrative Core of the SyneRx center to organize, supervise, and streamline all activities across Projects and Cores. It focuses on communication, milestone monitoring, and efficient infrastructure for new development and mentored projects, plus centralized fiscal and regulatory support. The goal is to keep the center productive and aligned toward developing antiviral therapies that can be used outside the hospital setting. By coordinating teams at Stanford and collaborating with other investigators, the core aims to accelerate timely progress toward drug development.
Why it matters
Potential benefit: If successful, patients could benefit from faster development and regulatory-ready outpatient antiviral options for coronaviruses and similar RNA viruses.
How similar studies have gone: Other NIH-funded centers with strong administrative cores have shown improved coordination and faster milestone achievement in antiviral development.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Glenn, Jeffrey S — Stanford University
- Study coordinator: Glenn, Jeffrey S
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.